|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001175,
umls-concept:C0010825,
umls-concept:C0012634,
umls-concept:C0017066,
umls-concept:C0442027,
umls-concept:C0449435,
umls-concept:C0679729,
umls-concept:C1257890,
umls-concept:C1547564,
umls-concept:C1708528,
umls-concept:C2603343
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
1996-6-13
|
|
pubmed:abstractText |
In the advanced stages of the acquired immunodeficiency syndrome (AIDS), cytomegalovirus (CMV) disease, particularly vision-damaging retinitis due to CMV is common. We evaluated prophylactic treatment with orally administered ganciclovir as a way to prevent CMV disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
pubmed-author:AndruczkRR,
pubmed-author:BuhlesWW,
pubmed-author:FollansbeeSS,
pubmed-author:HavlirD VDV,
pubmed-author:LalezariJ PJP,
pubmed-author:McKinleyG FGF,
pubmed-author:SammJJ,
pubmed-author:SimpsonGG,
pubmed-author:SpartiP DPD,
pubmed-author:SpectorS ASA,
pubmed-author:StempienMM,
pubmed-author:WongRR
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
6
|
|
pubmed:volume |
334
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1491-7
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8618603-AIDS-Related Opportunistic Infections,
pubmed-meshheading:8618603-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:8618603-Administration, Oral,
pubmed-meshheading:8618603-Adult,
pubmed-meshheading:8618603-CD4 Lymphocyte Count,
pubmed-meshheading:8618603-Cytomegalovirus Infections,
pubmed-meshheading:8618603-Double-Blind Method,
pubmed-meshheading:8618603-Female,
pubmed-meshheading:8618603-Ganciclovir,
pubmed-meshheading:8618603-Humans,
pubmed-meshheading:8618603-Male,
pubmed-meshheading:8618603-Prospective Studies,
pubmed-meshheading:8618603-Survival Analysis,
pubmed-meshheading:8618603-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.
|
|
pubmed:affiliation |
University of California, San Diego, La Jolla, 92093-0672, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
